Biotech8 months ago
Ysios Capital Invests in Engrail Therapeutics’ $157 Million Series B
Ysios Capital, specializing in biotech investments, will invest $157 million in Engrail Therapeutics, joining a syndicate led by F-Prime Capital. Engrail, founded in 2019, focuses on...